Vita Life Sciences Ltd
ASX:VLS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Vita Life Sciences Ltd
Revenue
Vita Life Sciences Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Vita Life Sciences Ltd
ASX:VLS
|
Revenue
AU$93.3m
|
CAGR 3-Years
12%
|
CAGR 5-Years
15%
|
CAGR 10-Years
9%
|
|
|
Recce Pharmaceuticals Ltd
ASX:RCE
|
Revenue
AU$1.1m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Revenue
AU$413m
|
CAGR 3-Years
38%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Revenue
AU$76.8m
|
CAGR 3-Years
69%
|
CAGR 5-Years
145%
|
CAGR 10-Years
44%
|
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Revenue
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Nyrada Inc
ASX:NYR
|
Revenue
AU$2.5m
|
CAGR 3-Years
7%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
Vita Life Sciences Ltd
Glance View
Vita Life Sciences Ltd. engages in the formulation, packaging, sale and distribution of vitamins and supplements. The company is headquartered in Sydney, New South Wales. The company went IPO on 2007-08-23. The firm is involved in the formulating, packaging, sales and distributing vitamins and supplements. The Company’s core business is the development and distribution of over the counter (OTC) medicines, as well as complementary and alternative medicines, dietary supplements and health foods under various brand names throughout Australia, Malaysia, Singapore, Thailand, Vietnam, China and Indonesia. The company offers products under the brands, such as Herbs of Gold, VitaHealth, VitaScience and VitaLife. The firm operates in Australia, Singapore, Malaysia and others. The firm subsidiaries include Tetley Research Pty Limited, Tetley Treadmills Pty Limited, Tetley Manufacturing Pty Limited, Vimed Bio Sciences Pty Limited, Allrad No 19 Pty Limited, Lovin Pharma International Limited, Herbs of Gold Pty Limited, VitaHealth Laboratories Australia Pty Limited and Vita Institute of Health Pty Ltd.
See Also
What is Vita Life Sciences Ltd's Revenue?
Revenue
93.3m
AUD
Based on the financial report for Dec 31, 2025, Vita Life Sciences Ltd's Revenue amounts to 93.3m AUD.
What is Vita Life Sciences Ltd's Revenue growth rate?
Revenue CAGR 10Y
9%
Over the last year, the Revenue growth was 17%. The average annual Revenue growth rates for Vita Life Sciences Ltd have been 12% over the past three years , 15% over the past five years , and 9% over the past ten years .
